Tag: Diagnostics Services Provider
Duo acts on Fortis Healthcare’s INR1.7bn buy of Agilus stake
Saraf & Partners and TT&A advised Fortis Healthcare on its INR1.77 billion (USD207 million) acquisition of a 31.52% stake in Agilus Diagnostics
Saraf & Partners and TT&A advised Fortis Healthcare on its INR1.77 billion (USD207 million) acquisition of a 31.52% stake in Agilus Diagnostics
Three INTA board members highlight AI branding, deepfakes and Asian enforcement reshaping trademark ownership, liability and protection
Follow us on LinkedIn